| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-05 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
| mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
ABT-263 |
FIMM |
pan-cancer |
AAC |
0.53 |
0.0003 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |